Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Biochemical Pharmacology
|
March 15, 1985
Separation of different UDP glucuronosyltransferase activities according to charge heterogeneity by chromatofocusing using mouse liver microsomes. Three major types of aglycones
P I Mackenzie, M M Joffe, P J Munson, et al.
Japanese Journal of Cancer Research : Gann
|
February 25, 1998
The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro
T Takahashi, Y Fujiwara, M Yamakido, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 17, 1998
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3
M D Green, C D King, B Mojarrabi, et al.
Molecular Pharmacology
|
June 17, 1998
C/EBPalpha is a regulator of the UDP glucuronosyltransferase UGT2B1 gene
A J Hansen, Y H Lee, E Sterneck, et al.
Drug Metabolism Reviews
|
November 27, 1999
Structural and functional studies of UDP-glucuronosyltransferases
A Radominska-Pandya, P J Czernik, J M Little, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 8, 2006
The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7
K Bowalgaha, D J Elliot, P I Mackenzie, et al.
Gastroenterology
|
May 1, 1995
Localization of uridine 5'-diphosphate-glucuronosyltransferase in human liver injury
H S Debinski, C S Lee, J A Danks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 1, 1997
Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds
C D King, G R Rios, M D Green, et al.
Cancer Research
|
January 15, 1997
Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drug
J O Miners, L Valente, K J Lillywhite, et al.
Biochemical and Biophysical Research Communications
|
March 29, 1991
Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9
M E Veronese, P I Mackenzie, C J Doecke, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Biochemical Pharmacology
|
March 15, 1985
Separation of different UDP glucuronosyltransferase activities according to charge heterogeneity by chromatofocusing using mouse liver microsomes. Three major types of aglycones
P I Mackenzie, M M Joffe, P J Munson, et al.
Japanese Journal of Cancer Research : Gann
|
February 25, 1998
The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro
T Takahashi, Y Fujiwara, M Yamakido, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 17, 1998
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3
M D Green, C D King, B Mojarrabi, et al.
Molecular Pharmacology
|
June 17, 1998
C/EBPalpha is a regulator of the UDP glucuronosyltransferase UGT2B1 gene
A J Hansen, Y H Lee, E Sterneck, et al.
Drug Metabolism Reviews
|
November 27, 1999
Structural and functional studies of UDP-glucuronosyltransferases
A Radominska-Pandya, P J Czernik, J M Little, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 8, 2006
The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7
K Bowalgaha, D J Elliot, P I Mackenzie, et al.
Gastroenterology
|
May 1, 1995
Localization of uridine 5'-diphosphate-glucuronosyltransferase in human liver injury
H S Debinski, C S Lee, J A Danks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 1, 1997
Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds
C D King, G R Rios, M D Green, et al.
Cancer Research
|
January 15, 1997
Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drug
J O Miners, L Valente, K J Lillywhite, et al.
Biochemical and Biophysical Research Communications
|
March 29, 1991
Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9
M E Veronese, P I Mackenzie, C J Doecke, et al.
Page
of 8